Therapeutic Potential of Vitamin D in Management of Asthma: A Literature Review
- PMID: 37588324
- PMCID: PMC10425698
- DOI: 10.7759/cureus.41956
Therapeutic Potential of Vitamin D in Management of Asthma: A Literature Review
Abstract
Asthma, a prevalent chronic respiratory illness, affects a substantial number of individuals worldwide, with an estimated occurrence of 358 million cases. Evidence for the benefits of vitamin D in treating asthma is ambiguous and contradictory. The goal of this review article is to emphasize the value of vitamin D supplementation for people with asthma. Medical subject headings (MeSH) terminology was used to search the PubMed Central, MEDLINE, and PubMed databases for articles on vitamin D supplementation in asthma patients. We selected a comprehensive range of academic writing examples published in English, encompassing various types of texts. The study included a total of 37 papers, of which 18 were randomized controlled trials (RCTs) and five were meta-analyses. The use of a corticosteroid, with or without the inclusion of an adrenergic receptor agonist, improves the disease's symptoms, but it is unable to halt the long-term decline in lung function. Over the past 20 years, vitamin D has developed into a potent immunomodulator, influencing both immunological and structural cells, most notably airway smooth muscle cells. Among adults with low 25-hydroxyvitamin D levels, the administration of vitamin D supplements was found to have positive effects in a reduction in the likelihood of asthma exacerbations requiring systemic corticosteroids. The provision of vitamin D supplements during pregnancy significantly reduces the risk of asthma in babies. Both children and adults with inadequate vitamin D levels who have been given vitamin D supplements have shown evident preventive effects against asthma. Therefore, we conclude there should be a lower threshold for prescribing vitamin D to patients with asthma who are vitamin D deficient.
Keywords: acute asthma managment; asthma; prevention; therapeutics; vitamin d.
Copyright © 2023, Tibrewal et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Vitamin D. Dixon KM, Mason RS. Int J Biochem Cell Biol. 2009;41:982–985. - PubMed
-
- Vitamin D in asthma. Is the golden bullet losing its luster? Upham JW, Sly PD. Am J Respir Crit Care Med. 2016;193:598–600. - PubMed
-
- Decoding the genetic and epigenetic basis of asthma. Stikker BS, Hendriks RW, Stadhouders R. Allergy. 2023;78:940–956. - PubMed
-
- Most recent national asthma data. [ Jul; 2023 ];Kuruvilla ME, Vanijcharoenkarn K, Shih JA, Lee FE. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm Respir Med. 2023 149:16–22. - PubMed
-
- Vitamin D in asthma: Mechanisms of action and considerations for clinical trials. Pfeffer PE, Hawrylowicz CM. Chest. 2018;153:1229–1239. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous